Efavirenz use during pregnancy and for women of child-bearing potential
<p>Abstract</p> <p>Background</p> <p>Efavirenz is the preferred non-nucleoside reverse transcriptase inhibitor for first-line antiretroviral treatment in many countries. For women of childbearing potential, advantages of efavirenz are balanced by concerns that it is teratogenic. This paper reviews e...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2006-04-01
|
| シリーズ: | AIDS Research and Therapy |
| オンライン･アクセス: | http://www.aidsrestherapy.com/content/3/1/11 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|